SAN JOSE, Calif., and SINGAPORE, Dec. 08, 2015 (GLOBE NEWSWIRE) -- Avago Technologies Limited (Nasdaq:AVGO), a leading semiconductor device supplier to the wireless, enterprise storage, wired, and industrial end markets, today announced that its Board of Directors has approved a quarterly, interim cash dividend of $0.44 per ordinary share.
The dividend is payable on December 30, 2015 to shareholders of record at the close of business (5:00 p.m.) Eastern Time on December 18, 2015.
About Avago Technologies Limited
Avago Technologies Limited is a leading designer, developer and global supplier of a broad range of analog, digital, mixed signal and optoelectronics components and subsystems with a focus in III-V compound and CMOS based semiconductor design and processing. Avago’s extensive product portfolio serves four primary target markets: wireless communications, enterprise storage, wired infrastructure, and industrial & other.
Contact: Avago Technologies Limited Ashish Saran Investor Relations +1 408 433 8000 [email protected]


Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Apple Turns 50: From Garage Startup to AI Crossroads
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 



